87916
Tebanicline ( Ebanicline , ABT-594 ) is a drug developed by Abbott , which acts as a partial agonist at neuronal nicotinic acetylcholine receptor s , binding to both the α3β4 and the α4β2 subtypes .
 organization: Abbott
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: location, person, organization 
Text: {0} 
 Entities: Abbott 
Answer:
 organization: Abbott